Trials / Completed
CompletedNCT00953628
Endometrial Advancement After Rec or u-HCG Triggering
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- Universitair Ziekenhuis Brussel · Academic / Other
- Sex
- Female
- Age
- 20 Years – 36 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate any potential advantages of replacing human chorionic gonadotropin (uhCG) with recombinant human chorionic gonadotropin (recHCG) for final oocyte maturation with regard to Ovarian hyperstimulation syndrome (OHSS)pathophysiology, endometrium receptivity and embryo quality and clinical pregnancy.
Detailed description
Biopsies of endometrium were taken in different groups Pregnancy rates were compared among defferent groups
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 10000 IU urinary HCG | bolus 10000 units for ovulation triggering |
| DRUG | 250 mcg recombinant HCG | bolus 250 mcg for ovulation triggering in IVF patients |
Timeline
- Start date
- 2005-08-01
- Primary completion
- 2006-12-01
- Completion
- 2008-12-01
- First posted
- 2009-08-06
- Last updated
- 2015-12-03
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00953628. Inclusion in this directory is not an endorsement.